Telix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLX) Stock Price Up 4.9% – Still a Buy?

Telix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLX) shares traded up 4.9% on Tuesday . The company traded as high as $16.60 and last traded at $16.60. 664 shares changed hands during mid-day trading, a decline of 97% from the average session volume of 19,786 shares. The stock had previously closed at $15.82.

Analyst Ratings Changes

Several equities analysts have issued reports on TLX shares. UBS Group initiated coverage on shares of Telix Pharmaceuticals Limited American Depositary Shares in a research note on Friday, November 15th. They issued a “buy” rating and a $21.00 price objective for the company. William Blair raised Telix Pharmaceuticals Limited American Depositary Shares to a “strong-buy” rating in a report on Tuesday, November 19th.

Telix Pharmaceuticals Limited American Depositary Shares Stock Up 0.1 %

Telix Pharmaceuticals Limited American Depositary Shares Company Profile

Telix Pharmaceuticals Limited is a biopharmaceutical company which focused on the development and commercialisation of therapeutic and diagnostic radiopharmaceuticals and associated medical technologies. It involved in developing a portfolio of clinical and commercial stage products that aims to address significant unmet medical needs in oncology and rare diseases.